These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17383993)

  • 41. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
    Konstantopoulos A; Williams CP; Luff AJ
    Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute endophthalmitis incidence: intravitreal triamcinolone.
    Westfall AC; Osborn A; Kuhl D; Benz MS; Mieler WF; Holz ER
    Arch Ophthalmol; 2005 Aug; 123(8):1075-7. PubMed ID: 16087840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraocular pressure alterations following intravitreal triamcinolone acetonide.
    Rhee DJ; Peck RE; Belmont J; Martidis A; Liu M; Chang J; Fontanarosa J; Moster MR
    Br J Ophthalmol; 2006 Aug; 90(8):999-1003. PubMed ID: 16597664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pseudo-endophthalmitis after intravitreal injection of triamcinolone.
    Sutter FK; Gillies MC
    Br J Ophthalmol; 2003 Aug; 87(8):972-4. PubMed ID: 12881337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection.
    Roth DB; Flynn HW
    Am J Ophthalmol; 2008 Sep; 146(3):346-347. PubMed ID: 18724979
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis.
    Pathengay A; Shah GY; Das T; Sharma S
    Am J Ophthalmol; 2006 May; 141(5):938-40. PubMed ID: 16678510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical characteristics and incidence of infectious and non-infectious endophthalmitis after intravitreous injection of triamcinolone acetonide].
    Magalhães E; Nehemy P; Santos DV; Fujji G; Nehemy MB
    Arq Bras Oftalmol; 2006; 69(6):791-4. PubMed ID: 17273669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravitreal triamcinolone.
    Tao Y; Jonas JB
    Ophthalmologica; 2011; 225(1):1-20. PubMed ID: 20693817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.